Hologic (NASDAQ:HOLX – Get Free Report) had its price objective increased by stock analysts at JPMorgan Chase & Co. from $85.00 to $91.00 in a note issued to investors on Friday, Benzinga reports. The firm currently has an “overweight” rating on the medical equipment provider’s stock. JPMorgan Chase & Co.‘s price objective points to a […]
Hologic (NASDAQ:HOLX – Get Free Report) released its earnings results on Thursday. The medical equipment provider reported $1.03 EPS for the quarter, topping the consensus estimate of $0.98 by $0.05, Briefing.com reports. The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1 billion. Hologic had a net margin […]
GAMMA Investing LLC acquired a new stake in Hologic, Inc. (NASDAQ:HOLX – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 2,085 shares of the medical equipment provider’s stock, valued at approximately $155,000. Other large investors also recently modified their holdings of the […]
Bank Julius Baer & Co. Ltd Zurich lowered its holdings in shares of Hologic, Inc. (NASDAQ:HOLX – Free Report) by 1.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 22,500 shares of the medical equipment provider’s stock after selling 277 shares during the […]